BioSort
PrivateLast Round
Early Funding
Feb 24, 2026
Total Funding Raised
$10.44M
Company Overview
BioSort is a technology company developing sensor-based equipment and AI to monitor fish health and improve sustainability in the aquaculture industry.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Computer Vision, Industrial Robotics, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioSort Comps
Public and private peers based on sector, stage, and business model.
BioSort Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Feb 24, 2026 |
Key People
Founding team and executive leadership
BioSort Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ichthus Venture Capital | Early Funding |
| Grieg Kapital | Early Funding |
| Farvatn | Early Funding |
| Futurum Ventures | Early Funding |
| Hatch Blue | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 24, 2026
$10.4M raised in early funding.
- Feb 24, 2026
Launched new sea lice control technology, funded by NOK 100M+ raise.
BioSort Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioSort's valuation, stock price, and market status.
